Scientists deliberately infect volunteers with malaria to study the disease

NCT ID NCT04083508

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to see if it's safe and possible to give healthy Thai adults a controlled infection of P. vivax malaria through mosquito bites. Six volunteers will be infected and monitored closely. The goal is to develop a reliable model for future research on malaria and immune responses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mosquito bites infected with P. vivax malaria

What this could lead to

If successful, this could create a reliable model to study P. vivax malaria and test future treatments or vaccines.

What could go wrong

This is a very early, tiny study (6 people) focused on feasibility, not treatment. It may not lead to any direct benefit for participants or patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLASMODIUM VIVAX INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Plasmodium vivax malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Faculty of Tropical Medicine

    RECRUITING

    Bangkok, 10400, Thailand

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••